Svb Wealth LLC Anavex Life Sciences Corp. Transaction History
Svb Wealth LLC
- $2.41 Billion
- Q1 2025
A detailed history of Svb Wealth LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Svb Wealth LLC holds 382 shares of AVXL stock, worth $4,232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
382Holding current value
$4,232% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
201Shares Held
30.9MCall Options Held
1.32MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$70.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$54.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$35.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$22.4 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$11.4 Million0.83% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $864M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...